Approval · Notice of Compliance 38447 · 2026
NEURAXPHARM-MODAFINIL: Notice of Compliance 38447
Issued October 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38447
- Date
- October 9, 2026
- Company
- Neuraxpharm Pharmaceuticals, S.L.Sant Joan Despi, Barcelona, Spain
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in product name. Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEURAXPHARM-MODAFINIL | 02420260 | Marketed |
Medicinal ingredients
- MODAFINIL 100 MG per TAB